Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Nat Rev Microbiol. 2017 Apr 10;15(7):422–434. doi: 10.1038/nrmicro.2017.28

Figure 3. The integration of next-generation sequencing and screening technologies with drug development and resistance surveillance.

Figure 3

The wide application of functional metagenomic selections and next-generation sequencing will steadily increase our knowledge of functionally annotated antibiotic resistance genes and their genetic context. This will enable more intelligent antibiotic resistance surveillance and drug design by accounting for specific mechanisms of resistance and the risk of resistance spread.